0001144204-14-005103.txt : 20140130 0001144204-14-005103.hdr.sgml : 20140130 20140130200218 ACCESSION NUMBER: 0001144204-14-005103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140128 FILED AS OF DATE: 20140130 DATE AS OF CHANGE: 20140130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd. CENTRAL INDEX KEY: 0001333763 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203174202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3530 TORINGDON WAY STREET 2: SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: 3530 TORINGDON WAY STREET 2: SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schmidt Keith CENTRAL INDEX KEY: 0001389235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51462 FILM NUMBER: 14562353 MAIL ADDRESS: STREET 1: C/O CHELSEA THERAPEUTICS, INC. STREET 2: 13950 BALLANTYNE CORPORATE PL, UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 4 1 v366692_4.xml OWNERSHIP DOCUMENT X0306 4 2014-01-28 0 0001333763 Chelsea Therapeutics International, Ltd. CHTP 0001389235 Schmidt Keith 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 0 1 0 0 Chief Commercial Officer Stock Option (Right to Buy) 4.50 2014-01-28 4 A 0 100000 0 A 2024-01-28 Common Stock 100000 100000 D Option vests in four equal annual installments beginning on January 28, 2015. /s/ Keith W. Schmidt 2014-01-30